Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Thang

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
JAAD International|December 22, 2025
Exposure to intravenous immunoglobulin is associated with increased mortality in patients on immune checkpoint inhibitors: A population-based cohort studyDebby Cheng, Nga Thi Thanh Nguyen, Christopher J Thang, et al.
Allergy|June 17, 2024
Evaluating alopecia areata risk among patients with seasonal and food allergies: A multicenter cohort studyDavid Garate, Christopher J Thang, Trevor L Murphy, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 25, 2026
Dupilumab Treatment for Atopic Dermatitis Associated with Reduced Risk of Alopecia Areata: A Multicenter Cohort StudyJasmine Levine, Alice Tang, Ross O'Hagan, et al.
The British Journal of Dermatology|May 31, 2024
Granuloma annulare and the risk of autoimmune conditions: a multicentre retrospective cohort analysisDavid Garate, Christopher J Thang, Madelyn Schmidt, et al.
Indian Journal of Orthopaedics|May 5, 2025
Base of Fifth Metatarsal Fractures: A Meta-analysis of Plate FixationKeenan Horani, Christopher J Thang, Sean O'Leary, et al.
Journal of the American Academy of Dermatology|October 1, 2025
Thromboembolic risk in dermatomyositis patients treated with intravenous immunoglobulin: A retrospective cohort study using the TriNetX databaseSara Khattab, Crystal T Chang, Katharina S Shaw, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 29, 2024
Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysisDavid Garate, Christopher J Thang, Crystal T Chang, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
JAAD International|December 22, 2025
Exposure to intravenous immunoglobulin is associated with increased mortality in patients on immune checkpoint inhibitors: A population-based cohort studyDebby Cheng, Nga Thi Thanh Nguyen, Christopher J Thang, et al.
Allergy|June 17, 2024
Evaluating alopecia areata risk among patients with seasonal and food allergies: A multicenter cohort studyDavid Garate, Christopher J Thang, Trevor L Murphy, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 25, 2026
Dupilumab Treatment for Atopic Dermatitis Associated with Reduced Risk of Alopecia Areata: A Multicenter Cohort StudyJasmine Levine, Alice Tang, Ross O'Hagan, et al.
The British Journal of Dermatology|May 31, 2024
Granuloma annulare and the risk of autoimmune conditions: a multicentre retrospective cohort analysisDavid Garate, Christopher J Thang, Madelyn Schmidt, et al.
Indian Journal of Orthopaedics|May 5, 2025
Base of Fifth Metatarsal Fractures: A Meta-analysis of Plate FixationKeenan Horani, Christopher J Thang, Sean O'Leary, et al.
Journal of the American Academy of Dermatology|October 1, 2025
Thromboembolic risk in dermatomyositis patients treated with intravenous immunoglobulin: A retrospective cohort study using the TriNetX databaseSara Khattab, Crystal T Chang, Katharina S Shaw, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 29, 2024
Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysisDavid Garate, Christopher J Thang, Crystal T Chang, et al.
Pageof 3